These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 6422313

  • 1. [Primary dysmenorrhea: current insights in etiology and treatment].
    Hein PR, Eskes TK.
    Ned Tijdschr Geneeskd; 1984 Jan 14; 128(2):73-8. PubMed ID: 6422313
    [Abstract] [Full Text] [Related]

  • 2. Dysmenorrhea.
    Dawood MY.
    J Reprod Med; 1985 Mar 14; 30(3):154-67. PubMed ID: 3158737
    [Abstract] [Full Text] [Related]

  • 3. Primary dysmenorrhea: current concepts.
    Voto SJ, Essig GF.
    Ohio State Med J; 1984 Aug 14; 80(8):606-9. PubMed ID: 6462599
    [Abstract] [Full Text] [Related]

  • 4. A rationale for the treatment of dysmenorrhea.
    Csapo AI.
    J Reprod Med; 1980 Oct 14; 25(4 Suppl):213-21. PubMed ID: 7001020
    [Abstract] [Full Text] [Related]

  • 5. [Dysmenorrhea induced by lumbosacral spine disorders. Pathogenesis, diagnosis and therapy with special emphasis on spinal manipulative therapy].
    Grgić V.
    Lijec Vjesn; 2009 Oct 14; 131(9-10):275-9. PubMed ID: 20030292
    [Abstract] [Full Text] [Related]

  • 6. Menstrual pain: its origin and pathogenesis.
    Rosenwaks Z, Seegar-Jones G.
    J Reprod Med; 1980 Oct 14; 25(4 Suppl):207-12. PubMed ID: 7001019
    [Abstract] [Full Text] [Related]

  • 7. Current status of the etiology and management of dysmenorrhea in adolescence.
    Alvin PE, Litt IF.
    Pediatrics; 1982 Oct 14; 70(4):516-25. PubMed ID: 6812011
    [No Abstract] [Full Text] [Related]

  • 8. [Drug therapy of dysmenorrhea].
    Zahradnik HP, Breckwoldt M.
    Gynakologe; 1988 Mar 14; 21(1):58-62. PubMed ID: 2897319
    [Abstract] [Full Text] [Related]

  • 9. [Dysmenorrhea].
    Ludwig H.
    Ther Umsch; 1996 Jun 14; 53(6):431-41. PubMed ID: 8767549
    [Abstract] [Full Text] [Related]

  • 10. Celecoxib in the treatment of primary dysmenorrhea: results from two randomized, double-blind, active- and placebo-controlled, crossover studies.
    Daniels S, Robbins J, West CR, Nemeth MA.
    Clin Ther; 2009 Jun 14; 31(6):1192-208. PubMed ID: 19695387
    [Abstract] [Full Text] [Related]

  • 11. Prostaglandins and nonsteroidal antiinflammatory drugs in dysmenorrhea.
    Chan WY.
    Annu Rev Pharmacol Toxicol; 1983 Jun 14; 23():131-49. PubMed ID: 6347048
    [Abstract] [Full Text] [Related]

  • 12. Treatment of primary dysmenorrhea and dysmenorrhea because of IUP with PG-synthetase inhibitors.
    Dreher E, von Fischer B.
    Adv Prostaglandin Thromboxane Res; 1980 Jun 14; 8():1487-93. PubMed ID: 6769316
    [Abstract] [Full Text] [Related]

  • 13. Zinc treatment prevents dysmenorrhea.
    Eby GA.
    Med Hypotheses; 2007 Jun 14; 69(2):297-301. PubMed ID: 17289285
    [Abstract] [Full Text] [Related]

  • 14. Effects of naproxen sodium on menstrual prostaglandins and primary dysmenorrhea.
    Chan WY, Fuchs F, Powell AM.
    Obstet Gynecol; 1983 Mar 14; 61(3):285-91. PubMed ID: 6571974
    [Abstract] [Full Text] [Related]

  • 15. Dysmenorrhoea and prostaglandins: pharmacological and therapeutic considerations.
    Dawood MY.
    Drugs; 1981 Jul 14; 22(1):42-56. PubMed ID: 6790261
    [Abstract] [Full Text] [Related]

  • 16. The effect of oral contraceptives on uterine contractility and menstrual pain: an assessment with cine MR imaging.
    Kido A, Togashi K, Kataoka M, Maetani Y, Nakai A, Kataoka ML, Koyama T, Fujii S.
    Hum Reprod; 2007 Jul 14; 22(7):2066-71. PubMed ID: 17567596
    [Abstract] [Full Text] [Related]

  • 17. Dysmenorrhea in adolescents and young adults: etiology and management.
    Harel Z.
    J Pediatr Adolesc Gynecol; 2006 Dec 14; 19(6):363-71. PubMed ID: 17174824
    [Abstract] [Full Text] [Related]

  • 18. Are combined oral contraceptives appropriate therapy for primary dysmenorrhea?
    Goodwin JH.
    J Nurse Midwifery; 1980 Dec 14; 25(2):17-9. PubMed ID: 6898647
    [Abstract] [Full Text] [Related]

  • 19. Effects of prostaglandin inhibition on vasopressin levels in women with primary dysmenorrhea.
    Strömberg P, Forsling ML, Akerlund M.
    Obstet Gynecol; 1981 Aug 14; 58(2):206-8. PubMed ID: 7254732
    [Abstract] [Full Text] [Related]

  • 20. Depo Provera. Position paper on clinical use, effectiveness and side effects.
    Bigrigg A, Evans M, Gbolade B, Newton J, Pollard L, Szarewski A, Thomas C, Walling M.
    Br J Fam Plann; 1999 Jul 14; 25(2):69-76. PubMed ID: 10454658
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.